- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lunit Inc (328130)
Lunit Inc stock price live, this page displays KQ 328130 stock exchange data. View the 328130 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lunit Inc real time stock price chart below.
What Is the Lunit Inc Stock Price Today?
The Lunit Inc stock price today is 20,850.
What Is the Stock Symbol for Lunit Inc?
The stock ticker symbol for Lunit Inc is 328130.
Is 328130 the Same as $328130?
$328130 is a common way to refer to the Lunit Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lunit Inc Trade On?
Lunit Inc is listed and trades on the KOSDAQ stock exchange.
Is Lunit Inc a Good Stock to Buy?
Determining whether Lunit Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lunit Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 328130 quote. (ISIN: KR7328130000)
What Is the Lunit Inc Stock Price Today?
The Lunit Inc stock price today is 20,850.
What Is the Stock Symbol for Lunit Inc?
The stock ticker symbol for Lunit Inc is 328130.
Is 328130 the Same as $328130?
$328130 is a common way to refer to the Lunit Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Lunit Inc Trade On?
Lunit Inc is listed and trades on the KOSDAQ stock exchange.
Is Lunit Inc a Good Stock to Buy?
Determining whether Lunit Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Lunit Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 328130 quote. (ISIN: KR7328130000)
KOSDAQ
Currency in KRW
20,850
-1,450(-6.50%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20,600
22,650
52 wk Range
15,333
40,750
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20,60022,650
52 wk Range
15,33340,750
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
328130 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Sell
Price Target
15,000
Downside
-28.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Health Care Technology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell
Analysts 12-Month Price Target:
Average 15,000
(-28.06% Downside)
Earnings
Latest Release
Mar 25, 2026
EPS / Forecast
-1,080.00 / --
Revenue / Forecast
26.48B / 28.2B
Compare 328130 to Peers and Sector
Metrics to compare | 328130 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship328130PeersSector | |
|---|---|---|---|---|
P/E Ratio | −27.6x | −4.2x | −0.5x | |
PEG Ratio | −18.88 | −0.04 | 0.00 | |
Price / Book | 9.5x | 1.6x | 2.6x | |
Price / LTM Sales | 15.7x | 7.1x | 3.2x | |
Upside (Analyst Target) | −32.7% | 39.1% | 48.3% | |
Fair Value Upside | Unlock | 17.7% | 5.6% | Unlock |
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations; with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development; and with Daiichi Sankyo Company, Limited to accelerate biomarker discovery and translational research. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lunit (328130) Stock Price Today?
The Lunit stock price today is 20,850 KRW.
What Stock Exchange Does Lunit Trade On?
Lunit is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Lunit?
The stock symbol for Lunit is "328130."
What Is the Lunit Market Cap?
As of today, Lunit market cap is 1.31T KRW.
What Is Lunit's Earnings Per Share (TTM)?
The Lunit EPS (TTM) is -813.
When Is the Next Lunit Earnings Date?
Lunit will release its next earnings report on May 19, 2026.
From a Technical Analysis Perspective, Is 328130 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lunit Stock Split?
Lunit has split 2 times.
What is the current trading status of Lunit (328130)?
As of May 07, 2026, Lunit (328130) is trading at a price of 20,850 KRW, with a previous close of 22,300 KRW. The stock has fluctuated within a day range of 20,600 KRW to 22,650 KRW, while its 52-week range spans from 15,333 KRW to 40,750 KRW.
What Is Lunit (328130) Price Target According to Analysts?
The average 12-month price target for Lunit is 15,000 KRW, with a high estimate of 15000 KRW and a low estimate of 15000 KRW. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an -28.06% Downside potential.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.